You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

126 Results
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Myeloid (AML)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Funding:
Exceptional Access Program
    First-line treatment of adult patients diagnosed with FLT3-mutated acute myeloid leukemia, in combination with specific standard induction followed by consolidation chemotherapy, according to clinical criteria
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
cytarabine,
midostaurin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Oct 2018
Guidelines and Advice
Status: Current
ID: GL-C50-19
Jan 2015
Guidelines and Advice
Status: Current
Version: 2
Oct 2018
Statistical Reports
Jan 2018
Cancer facts
Jan 2018
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB - General Benefit
    prednisone
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
cyclophosphamide,
vinCRIStine,
prednisone
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jan 2018
Drug
Quick Link(s): Patient Info Sheet
Jan 2018
Drug
Quick Link(s): Patient Info Sheet
Jan 2018
Regimen
Cancer Type:
Gynecologic, 
Cervix
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Drugs Used:
CARBOplatin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jan 2018
Guidelines and Advice
Status: Current
ID: GL 8-11
Jan 2018
Guidelines and Advice
Status: Current
ID: GL-END 3-21
Jan 2018
Guidelines and Advice
Status: Current
Version: 1
Jan 2018

Pages